malondialdehyde has been researched along with Opioid-Related Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi, S; Khazaie, H; Kiani, A; Moini, A; Najafi, K; Rahpeyma, M; Vaisi-Raygani, A | 1 |
| Aghadavod, E; Asemi, Z; Bahmani, F; Banafshe, HR; Ghaderi, A; Karimi, MA; Mansournia, MA; Mehrzad, F; Mirhosseini, N; Motmaen, M; Reiter, RJ | 1 |
| Abdel-Rahman, MS; Abdel-Zaher, AO; Elwasei, FM | 1 |
| Atici, S; Cinel, I; Cinel, L; Doruk, N; Eskandari, G; Oral, U | 1 |
| Antonova, TV; Bol'shakova, AI; Nikolaenko, SL | 1 |
1 trial(s) available for malondialdehyde and Opioid-Related Disorders
| Article | Year |
|---|---|
The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment.
Topics: Adult; Analgesics, Opioid; Antioxidants; Anxiety; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Depression; Double-Blind Method; Gene Expression; Glutathione; Humans; Insulin Resistance; Interleukin-1; Male; Malondialdehyde; Melatonin; Mental Health; Methadone; Middle Aged; Nitric Oxide; Opiate Substitution Treatment; Opioid-Related Disorders; Penile Erection; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sleep; Transforming Growth Factor beta; Triglycerides; Tumor Necrosis Factor-alpha | 2019 |
4 other study(ies) available for malondialdehyde and Opioid-Related Disorders
| Article | Year |
|---|---|
Study of Serum Malondialdehyde Level in Opioid and Methamphetamine Dependent Patients.
Topics: Amphetamine-Related Disorders; Analgesics, Opioid; Antioxidants; Case-Control Studies; Chromatography, High Pressure Liquid; Humans; Lipid Peroxidation; Malondialdehyde; Methamphetamine; Opioid-Related Disorders; Oxidative Stress; Thiobarbiturates | 2017 |
Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress.
Topics: Analgesics, Opioid; Animals; Antioxidants; Behavior, Animal; Brain; Drug Tolerance; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Male; Malondialdehyde; Mice; Narcotic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Opioid-Related Disorders; Oxidative Stress; Pain Threshold; Plant Oils; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Time Factors; Tramadol | 2011 |
Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Kidney; L-Lactate Dehydrogenase; Lipid Peroxides; Liver; Male; Malondialdehyde; Morphine; Opioid-Related Disorders; Rats; Rats, Wistar; Tramadol | 2005 |
[Characteristics of viral hepatitis in addicts with consideration of lymphocyte membrane condition].
Topics: Acute Disease; Adolescent; Adult; Biomarkers; Cell Membrane; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lipid Peroxidation; Lymphocytes; Male; Malondialdehyde; Opioid-Related Disorders; Severity of Illness Index; Substance Abuse, Intravenous; Superoxide Dismutase | 1998 |